Show simple item record

Authordc.contributor.authorGaldames Poblete, 
Authordc.contributor.authorSilva-Rosas, 
Authordc.contributor.authorAguilera Olivares, 
Admission datedc.date.accessioned2019-01-29T15:49:55Z
Available datedc.date.available2019-01-29T15:49:55Z
Publication datedc.date.issued1994
Cita de ítemdc.identifier.citationNeurologia, Volumen 9, Issue 3, 2018, Pages 109-111
Identifierdc.identifier.issn02134853
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/162485
Abstractdc.description.abstractMidazolam is a water-soluble benzodiazepine imide that has been used in recent years to manage status epilepticus (SE). We describe four patients with SE refractory to conventional treatment, whose seizures were controlled with midazolam administered intramuscularly in two cases and intravenously in the remaining two. Given the pharmacokinetic traits of this drug, the intramuscular route offers great advantages. Midazolam also produces fewer side effects than do other benzodiazepines, suggesting the possibility of its use as a first line treatment for SE and frequent epileptic seizures.
Lenguagedc.language.isoen
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceNeurologia
Keywordsdc.subjectmidazolam
Keywordsdc.subjectstatus epilepticus
Títulodc.titleTreatment of status epilepticus with midazolam: Four cases TRATAMIENTO DEL ESTADO DE MAL EPILEPTICO CON MIDAZOLAM: PRESENTACION DE 4 CASOS
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile